SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-18-007895
Filing Date
2018-02-09
Accepted
2018-02-09 11:40:44
Documents
1
Group Members
CAPITAL VENTURES INTERNATIONALG1 EXECUTION SERVICES, LLCSUSQUEHANNA ADVISORS GROUP, INCSUSQUEHANNA INVESTMENT GROUP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5549_7sc13ga.htm SC 13G/A 155067
  Complete submission text file 0001104659-18-007895.txt   157070
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 18589698
SIC: 2834 Pharmaceutical Preparations

Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA SECURITIES (Filed by) CIK: 0001446580 (see all company filings)

IRS No.: 232754552
Type: SC 13G/A